Berenberg initiated coverage of Fresenius Medical (FMS) American depository receipts with a Buy rating and $25.60 price target The firm believes the company is receiving little credit for its earnings turnaround and deleveraging efforts.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS: